For U.S. hospice agencies
Hospice Helper reviews every chart, monitors HOPE and HQRP performance in real time, and maintains a complete, surveyor-ready record of every finding and resolution — so your clinical and administrative teams can devote their attention to patient care.
The platform
Hospice Helper connects to the EHR your agency already uses, ingests the clinical record, and applies a citation-aligned audit engine and AI-assisted review to every chart, every day. Four integrated modules share the same canonical record, the same findings, and the same verifiable history.
Explore the full productEvery chart in the active census is reviewed continuously against a library of audit checks aligned to specific CMS citations. Findings are surfaced on a daily worklist with direct links to the records that triggered them, so clinical leaders can resolve issues while they remain correctable.
HUV1 and HUV2 windows are tracked in the agency's local time zone, Symptom Follow-Up Visits are armed automatically when moderate or severe symptoms are recorded, and HQRP measure performance — HCI, HVLDL, CAHPS, and the Comprehensive Assessment — is monitored on a continuous basis.
Findings from the audit engine flow directly into the QAPI workspace, supporting the annual evaluation, Performance Improvement Projects, IDG attendance reporting, and the artifacts surveyors expect — without parallel spreadsheets or year-end reconstruction.
On-demand reports compile every applicable Condition of Participation, every audit finding, every resolution, and every access record — scoped to ACHC, CHAP, TJC, or state survey requirements — and produced in the formats accreditors recognize.
Outcomes for the agency
Audit checks, citation tracking, and quality reporting run continuously in the background. The hours your team would have spent assembling evidence return to patient visits, family conversations, and clinical leadership.
Issues are surfaced in the days they occur — not in the surveyor's exit conference. Deficiencies are remediated on the record, with a complete history of when and how.
HOPE submission timing, HUV completion, and HQRP measure performance are visible at all times. Exposure to the four-percentage-point APU reduction is a managed metric, not a year-end discovery.
The compliance landscape
Survey citations, payment integrity, and accreditation each carry consequences that compound quickly. Four areas, in particular, generate most of the operational and financial risk hospice agencies face today.
Deficiencies under 42 CFR §418.56 — care plans not individualized, not updated within the 15-day interdisciplinary group review, or not aligned with the services delivered — are consistently among the most frequently cited findings in hospice surveys.
Vague terminal-prognosis narratives, missing clinical summaries, and late or undocumented face-to-face encounters under §418.22 and §418.24 remain a leading source of survey citations and downstream payment denials.
Since October 1, 2025, HOPE replaced HIS as the standardized assessment instrument. HUV1 (days 6–15), HUV2 (days 16–30), and Symptom Follow-Up Visits within two calendar days of moderate or severe symptoms must be tracked precisely — and submitted to iQIES on a strict schedule.
At least 90% of required quality records must be submitted within 30 days. Failure carries a four-percentage-point reduction to the Annual Payment Update — for FY 2026, the difference between a 2.6% increase and a 1.4% decrease against the hospice market basket.
Figures reflect published CMS requirements for HOPE and the Hospice Quality Reporting Program.
Grounded in the regulations
Findings are tagged to the Condition of Participation, HOPE timepoint, or HQRP measure they concern, so a surveyor, an accreditor, or your own QAPI committee can trace each one back to the requirement behind it.
See the regulatory anchors for each moduleCurrent status
Hospice Helper is preparing to onboard its first hospice agencies. Customer case studies will be published as those engagements mature.
Next step
Tell us about your agency and we will scope the deployment with you — starting with a walkthrough on a sanitized sample of your data, or a fully synthetic dataset if you prefer not to share charts before a Business Associate Agreement is in place.
